{"headerData":{"lastRefreshDate":"14 Apr 2026"},"publicationOverview":{"publication":{"id":"259DE38C-3F51-42CD-B6A9-95941B99E508","resourceUrl":"http://gtr.ukri.org/api/publication/overview?outcomeid=6106b6a125d95&projectref=#grantRef#","outcomeId":"6106b6a125d95","title":"Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial","parentPublicationTitle":null,"authors":[{"id":"a175bb6bdd559923b7a9e64a4b5b8fe0","resourceUrl":"http://gtr.ukri.org/api/person/a175bb6bdd559923b7a9e64a4b5b8fe0","firstName":null,"otherNames":"Fisher B","surname":null,"email":null,"orcidId":null,"displayName":"Fisher B","fullName":"Fisher B"}],"date":1609459200000,"digitalPublicationUrl":"http://dx.doi.org/10.1101/2021.06.02.21258204","pubMedId":null,"pubMedUrl":null,"isbn":null,"issn":null,"publicationUrl":"http://dx.doi.org/10.1101/2021.06.02.21258204","abstractText":null,"volume":null,"issue":null,"totalPages":null,"edition":null,"chapterNumber":null,"chapterTitle":null,"pageRef":null,"series":null,"type":"Preprint","firstAuthorName":"Fisher B","grantRef":null},"projects":[{"id":"8C63F607-7119-477C-80CD-A77AD68698FE","resourceUrl":"http://gtr.ukri.org/projects?ref=MC_PC_20007","title":"CATALYST a randomised early phase adaptive trial for new drugs for SARS-CoV-2+ patients","status":null,"grantReference":"MC_PC_20007","grantCategory":"Intramural","abstractText":null,"potentialImpactText":null,"fund":{"valuePounds":450000,"start":null,"end":null,"funder":{"id":"47D1BADC-597A-4B3F-8462-4C3BF3018C12","resourceUrl":"http://gtr.ukri.org/api/organisation/47D1BADC-597A-4B3F-8462-4C3BF3018C12","name":"COVID"},"type":"EXPENDITURE_ACTUAL"},"output":null,"publications":null,"identifiers":null,"technicalSummary":null,"projectHierarchy":null,"studentshipHierarchy":null,"healthCategories":[],"researchActivities":[],"researchSubjects":[],"researchTopics":[],"rcukProgrammes":[],"hasClassifications":false}],"abstractSnippet":null}}